Skip to main content
. 2021 Mar 9;36(11):e77. doi: 10.3346/jkms.2021.36.e77

Fig. 2. Estimated proportion of the patients received reperfusion therapy by ground transport time.

Fig. 2

(A) IVT, unadjusted analysis (P = 0.003); (B) IVT, adjusted analysis (P = 0.006); adjusted for age, hypertension, diabetes, atrial fibrillation, stroke history, coronary artery disease, use of an antiplatelet agent, oral anticoagulants or statins before the index stroke, diastolic blood pressure, fasting blood glucose, low-density lipoprotein cholesterol, platelet count, onset-to-arrival time, initial NIHSS score, and TOAST classification. (C) EVT, unadjusted analysis (P = 0.090); (D) EVT, adjusted analysis (P = 0.100); adjusted for age, sex, hypertension, diabetes, atrial fibrillation, hyperlipidemia, smoking, coronary artery disease, use of an antiplatelet agent or oral anticoagulants before the index stroke, systolic blood pressure, hemoglobin, platelet count, blood urea nitrogen, onset-to-arrival time, initial NIHSS score, and TOAST classification.

IVT = intravenous thrombolysis, EVT = endovascular therapy, NIHSS = National Institutes of Health Stroke Scale, TOAST = Trial of Org 10172 in Acute Stroke Treatment.